| Patient | Cleopatra |
|---|---|
| Date of birth | 1997-01-15 |
| Identifiers | MRN HR-AC003-SYN; SSN (made up) 000-03-7095 |
| Document date | 2026-08-18 |
| Author | Nefeli Arvanitis-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Prenatal visit at 33 weeks: growth scan, Tdap, and the delivery plan. [S]
Cleopatra returns at 33 weeks 0 days. The visit and growth scan planned for 29 weeks did not take place: the scan request was not sent when the visit was booked, the visit was cancelled when no scan slot appeared, and neither was rebooked until she called the clinic last week. She has felt well. She has had no headache, visual change, upper abdominal pain, swelling of the face or hands, breathlessness, bleeding, leaking fluid, or regular tightenings; she has occasional painless tightenings in the evening. Both babies move often. She takes aspirin, the prenatal vitamin, and ferrous sulfate every other day. She has stopped evening meetings and plans to stop work at 36 weeks. She had the growth scan this morning and wants to plan the birth. [S]
| Element | Detail |
|---|---|
| Missed care | The 29-week visit and growth scan did not take place |
| Symptoms | None of preeclampsia; occasional painless evening tightenings |
| Fetal movement | Both babies moving often |
| Plans | Stopping work at 36 weeks |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Well; tired by evening |
| Cardiovascular | Negative | No breathlessness or palpitations |
| Neurological | Negative | No headache or visual change |
| Gastrointestinal | Negative | No upper abdominal pain; mild heartburn |
| Genitourinary | Negative | No bleeding, leaking fluid, or urinary symptoms |
| Psychiatric | Negative | Calm and looking forward; EPDS 6 |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Prenatal vitamin containing folic acid 0.4 mg, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-03 | active | S |
| Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth every other day | One tablet every other morning with water or orange juice, apart from tea, coffee, and calcium | Oral route | 2026-03-03 | active | S |
| Doxylamine succinate 10 mg / pyridoxine hydrochloride 10 mg delayed-release tablet, two tablets by mouth at bedtime | Two tablets at bedtime; may add one in the morning if needed | Oral route | 2026-03-03 to 2026-05-12 | completed | S |
| Aspirin 81 mg delayed-release tablet, one tablet by mouth at bedtime | One tablet by mouth at bedtime from 12 weeks until delivery | Oral route | 2026-03-24 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-08-18 | Body height | 165 | cm | S |
| 2026-08-18 | Body weight | 70.5 | kg | S |
| 2026-08-18 | Body mass index (BMI) [Ratio] | 25.9 | kg/m2 | S |
| 2026-08-18 | Systolic blood pressure | 114 | mm[Hg] | S |
| 2026-08-18 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-08-18 | Heart rate | 92 | /min | S |
| 2026-08-18 | Respiratory rate | 16 | /min | S |
| 2026-08-18 | Body temperature | 36.8 | Cel | S |
| 2026-08-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-08-18 | Hemoglobin [Mass/volume] in Blood | 11 | g/dL | 11-15 g/dL | Normal | S |
| 2026-08-18 | Platelets [#/volume] in Blood by Automated count | 226 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-08-18 | Fetal Body weight estimated by US | 2050 | g | About the 45th centile for 33 weeks | Normal | S |
| 2026-08-18 | Fetal Body weight estimated by US | 1890 | g | About the 30th centile for 33 weeks; discordance 8 percent | Normal | S |
| 2026-08-18 | Total score [EPDS] | 6 | {score} | S |
Vital signs recorded on 2026-08-18; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well |
| Abdomen | Fundal height 38 cm, consistent with twins at 33 weeks; non-tender |
| Fetal | Scan: twin A cephalic, 2050 g; twin B breech, 1890 g; discordance 8 percent; normal fluid; fetal hearts 140 and 136 per minute |
| Extremities | Trace ankle edema; no calf tenderness |
| Urine dipstick | Protein negative |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Uterus larger than dates in early pregnancy: 9 weeks by a certain last menstrual period, with the uterus about 12 to 13 weeks in size; nausea and vomiting heavier than in her first pregnancy; no bleeding; cause not yet known (multiple pregnancy, dating error, fibroids, or molar pregnancy) | resolved | confirmed | O26.841 | S — Synthetic presenting finding anchored to the documented conception in the winter of 41 to 40 BC; it resolves when the ultrasound explains it. |
| Nausea and vomiting of pregnancy, moderate (PUQE score 9); keeping fluids down; no weight loss or ketonuria | resolved | confirmed | O21.9 | S — Synthetic; nausea is common and often heavier in early pregnancy with a large uterus. |
| Iron deficiency anemia in pregnancy: hemoglobin 10.8 g/dL, MCV 79 fL, ferritin 14 ng/mL | active | confirmed | O99.011 | S — Synthetic finding; it echoes no documented diagnosis. |
| Twin pregnancy, dichorionic diamniotic, second pregnancy (gravida 2, para 1): two live fetuses with a thick dividing membrane and a twin-peak (lambda) sign at 11 weeks; dated by her last period, confirmed by the crown-rump lengths | active | confirmed | O30.041 | S — Synthetic modern diagnosis anchored to the documented twins of 40 BC; chorionicity is a modern finding and makes no claim about her real pregnancy. |
| Acute viral gastroenteritis at 22 weeks in a twin pregnancy, with mild dehydration and painless tightenings; no preterm labor (cervical length 39 mm); resolved with oral rehydration | resolved | confirmed | O98.512 | S — Synthetic intercurrent illness at an unscheduled visit, chosen to teach the assessment of tightenings and dehydration in a twin pregnancy; it echoes no documented illness. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure and urine protein | Every prenatal visit | Completed today | 114/72 mmHg; urine protein negative |
| Examination | Prenatal visit and growth scan at 29 weeks | Every four weeks for growth scans; visits every two weeks from 28 weeks | Deferred | Missed: the 29-week visit and growth scan did not take place because the scan request was not sent and the cancelled visit was not rebooked. No harm found today: blood pressure 114/72 mmHg, no proteinuria, no symptoms, and concordant growth with normal fluid on today's scan. Corrective action: all remaining visits and the 36-week scan were booked together today, and the clinic is reviewing how scan requests are linked to visits |
| Examination | Fetal hearts and fundal height | Every prenatal visit | Completed today | Fetal hearts 140 and 136 per minute; fundal height 38 cm |
| Examination | Weight gain (about 17 to 25 kg for twins from a normal BMI) | Every prenatal visit | Completed today | 70.5 kg, up 12.5 kg since intake |
| Imaging | Growth scan with discordance | Every four weeks from about 20 to 24 weeks in a dichorionic twin pregnancy | Completed today | 2050 and 1890 g; discordance 8 percent; normal fluid and Doppler; twin A cephalic, twin B breech |
| Laboratory | Hemoglobin and ferritin | At intake, at the anatomy-scan visit, at 24 to 28 weeks, and in the third trimester | Completed today | Hemoglobin 11.0 g/dL; platelets 226 |
| Survey | Perinatal mood screen (EPDS) | Each trimester | Completed today | 6; item 10 scored 0 |
| Medication safety | Tdap vaccine | Once at 27 to 36 weeks in every pregnancy | Completed today | Given today |
| Medication safety | RSV vaccine | At 32 to 36 weeks from September to January | Due | At the 36-week visit in September |
| Laboratory | Group B streptococcus culture | At 36 0/7 to 37 6/7 weeks | Due | At the 36-week visit |
| Examination | Weekly antenatal fetal testing | May be considered from 36 0/7 weeks in uncomplicated dichorionic twins | Due | From 36 weeks |
| Medication safety | Low-dose aspirin | Daily from 12 weeks until delivery; review at every visit | Completed today | Taken nightly; continue until delivery |
| Self-management | Delivery timing and place | Agreed by 34 weeks | Completed today | Induction at 38 weeks 0 days at the hospital with a neonatal intensive care unit |
| Self-management | Preterm labor warning signs | Every prenatal visit | Completed today | Occasional painless evening tightenings only; warning signs reviewed |
Goal progress:
Immunizations given today: Tdap vaccine in pregnancy, 33 weeks [S]
Guideline basis: Multifetal Gestations: Twin, Triplet, and Higher-Order Multifetal Pregnancies: ACOG Practice Bulletin, Number 231 (2021); Medically Indicated Late-Preterm and Early-Term Deliveries: ACOG Committee Opinion, Number 831 (2021); Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234 (2021); Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021); Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum: ACOG Clinical Practice Guideline No. 4 (2023); Guidelines for Vaccinating Pregnant Persons (2026)
Follow-up: Prenatal visits every two weeks until 36 weeks, then weekly; growth scan at 36 to 37 weeks; induction at 38 weeks 0 days. [S]